A Systematic Review of Adherence to Oral Antineoplastic Therapies - PubMed (original) (raw)

Review

A Systematic Review of Adherence to Oral Antineoplastic Therapies

Joseph A Greer et al. Oncologist. 2016 Mar.

Abstract

Background: Oral antineoplastic therapies not only improve survival but also reduce the burden of care for patients. Yet patients and clinicians face new challenges in managing adherence to these oral therapies. We conducted a systematic literature review to assess rates and correlates of adherence to oral antineoplastic therapies and interventions aimed at improving adherence.

Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive literature search of the Ovid MEDLINE database from January 1, 2003 to June 30, 2015, using relevant terminology for oral antineoplastic agents. We included observational, database, and intervention studies. At least two researchers evaluated each paper to ensure accuracy of results and determine risk of bias.

Results: We identified 927 records from the search and screened 214 abstracts. After conducting a full-text review of 167 papers, we included in the final sample 51 papers on rates/correlates of adherence to oral antineoplastic therapy and 12 papers on intervention studies to improve adherence. Rates of adherence varied widely, from 46% to 100%, depending on patient sample, medication type, follow-up period, assessment measure, and calculation of adherence. Of the intervention studies, only 1 of the randomized trials and 2 of the cohort studies showed benefit regarding adherence, with the majority suffering high risk of bias.

Conclusions: Although no reliable estimate of adherence to oral antineoplastic therapies can be gleaned from the literature, a substantial proportion of patients struggle to adhere to these medications as prescribed. The few intervention studies for adherence have notable methodological concerns, thereby limiting the evidence to guide practice in promoting medication adherence among patients with cancer.

Keywords: Antineoplastic agents; Chemotherapy; Endocrine therapy; Medication adherence; Oral drug administration; Patient adherence.

©AlphaMed Press.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1.

Figure 1.

Flowchart for selection of studies for inclusion in the systematic review.

None

Similar articles

Cited by

References

    1. O’Neill VJ, Twelves CJ. Oral cancer treatment: Developments in chemotherapy and beyond. Br J Cancer. 2002;87:933–937. - PMC - PubMed
    1. Findlay M, von Minckwitz G, Wardley A. Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol. 2008;19:212–222. - PubMed
    1. Borner M, Scheithauer W, Twelves C, et al. Answering patients’ needs: Oral alternatives to intravenous therapy. The Oncologist. 2001;6(suppl 4):12–16. - PubMed
    1. Weingart SN, Brown E, Bach PB, et al. NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw. 2008;6(suppl 3):S1–S14. - PubMed
    1. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44–47. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources